Inhibrx Stock Price on December 17, 2024
INBX Stock | USD 14.47 0.13 0.89% |
Below is the normalized historical share price chart for Inhibrx extending back to August 19, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Inhibrx stands at 14.47, as last reported on the 25th of December, with the highest price reaching 14.77 and the lowest price hitting 13.79 during the day.
If you're considering investing in Inhibrx Stock, it is important to understand the factors that can impact its price. Inhibrx holds Efficiency (Sharpe) Ratio of -0.0226, which attests that the entity had a -0.0226% return per unit of risk over the last 3 months. Inhibrx exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Inhibrx's Market Risk Adjusted Performance of (0.39), risk adjusted performance of (0.04), and Standard Deviation of 2.57 to validate the risk estimate we provide.
At this time, Inhibrx's Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 323.3 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 38.2 M in 2024. . At this time, Inhibrx's Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 43.23 in 2024, whereas Price Earnings Ratio is likely to drop (7.79) in 2024. Inhibrx Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 19th of August 2020 | 200 Day MA 14.7545 | 50 Day MA 15.2469 | Beta 2.877 |
Inhibrx |
Sharpe Ratio = -0.0226
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | INBX |
Estimated Market Risk
2.59 actual daily | 23 77% of assets are more volatile |
Expected Return
-0.06 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Inhibrx is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Inhibrx by adding Inhibrx to a well-diversified portfolio.
Price Book 1.1737 | Enterprise Value Ebitda 0.0087 | Price Sales 124.165 | Shares Float 7.7 M | Wall Street Target Price 15 |
Inhibrx Main Headline on 17th of December 2024
Inhibrxs SWOT analysis biotech stock faces pivotal year amid... by investing.com
Inhibrxs SWOT analysis biotech stock faces pivotal year amid clinical trials
Inhibrx Valuation on December 17, 2024
It is possible to determine the worth of Inhibrx on a given historical date. On December 17, 2024 Inhibrx was worth 14.32 at the beginning of the trading date compared to the closed value of 14.55. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Inhibrx stock. Still, in general, we apply an absolute valuation method to find Inhibrx's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Inhibrx where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Inhibrx's related companies.
Open | High | Low | Close | Volume | |
14.52 | 14.71 | 14.44 | 14.56 | 42,160 | |
12/17/2024 | 14.32 | 14.81 | 14.19 | 14.55 | 74,067 |
14.57 | 15.24 | 13.70 | 14.09 | 115,365 |
Backtest Inhibrx | | | Inhibrx History | | | Inhibrx Valuation | Previous | Next |
Inhibrx Trading Date Momentum on December 17, 2024
On December 18 2024 Inhibrx was traded for 14.09 at the closing time. The top price for the day was 15.24 and the lowest listed price was 13.70 . The trading volume for the day was 115.4 K. The trading history from December 18, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 3.16% . The trading delta at closing time against the current closing price is 1.03% . |
Inhibrx Fundamentals Correlations and Trends
By evaluating Inhibrx's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Inhibrx's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Inhibrx financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Inhibrx Stock history
Inhibrx investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Inhibrx is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Inhibrx will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Inhibrx stock prices may prove useful in developing a viable investing in Inhibrx
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 47.1 M | 38.2 M | |
Net Loss | -130.7 M | -124.2 M |
Inhibrx Stock Technical Analysis
Inhibrx technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Inhibrx Period Price Range
Low | December 25, 2024
| High |
0.00 | 0.00 |
Inhibrx cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Inhibrx December 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Inhibrx stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Inhibrx shares will generate the highest return on investment. By undertsting and applying Inhibrx stock market strength indicators, traders can identify Inhibrx entry and exit signals to maximize returns
Inhibrx Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Inhibrx's price direction in advance. Along with the technical and fundamental analysis of Inhibrx Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Inhibrx to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.04) | |||
Jensen Alpha | (0.17) | |||
Total Risk Alpha | (0.27) | |||
Treynor Ratio | (0.40) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Inhibrx Stock Analysis
When running Inhibrx's price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.